Breast Cancer Clinical Trial

BRAVE Strategy – Breast Cancer Risk Assessment -achieVing Equity

Summary

The central goal of this study is to test strategies to implement evidence-based breast cancer risk assessment in healthcare clinics in Tennessee. The BRAVE Strategy (Breast cancer Risk Assessment - achieVing Equity) study aims to assess the feasibility, reach, acceptability, and appropriateness of select customized strategies to increase uptake of breast cancer risk assessment. The investigators will achieve these aims through a conducting a stepped-wedge trial conducted in 10 healthcare clinics in the state of Tennessee. The primary outcome is the proportion of women age 25-49 having risk assessment. Secondary outcomes include the numbers of 1) women identified as high-risk; 2) pursuing risk-adherent screening; and 3) diagnosed with breast cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

ages 25-49

Exclusion Criteria:

personal history of breast cancer

Study is for people with:

Breast Cancer

Estimated Enrollment:

500

Study ID:

NCT05051631

Recruitment Status:

Recruiting

Sponsor:

Vanderbilt University Medical Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Vanderbilt University Medical Center
Nashville Tennessee, 37232, United States More Info
Lucy B Spalluto, MD MPH
Contact
615-322-1585
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

500

Study ID:

NCT05051631

Recruitment Status:

Recruiting

Sponsor:


Vanderbilt University Medical Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.